Zydus Healthcare gets CDSCO Panel nod to conduct Phase III CT of Glycopyrrolate plus Indacaterol Metered Dose Inhalation Dr. Divya Colin13 April 2025 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to Zydus...
Zydus Healthcare Gets CDSCO Panel Nod To study Vilanterol plus Umeclidinium powder for inhalation Dr. Divya Colin9 April 2025 6:00 PM ISTNew Delhi: Zydus Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Submit active controlled CT design for moderate to very severe COPD patients: CDSCO Panel tells Zydus Healthcare on Revefenacin inhalation Dr. Divya Colin16 Nov 2024 6:00 PM ISTNew Delhi: Responding to Zydus Healthcare's proposal to manufacture and market Revefenacin Inhalation Solution 175 mcg/3ml, the Subject Expert...
AstraZeneca gets CDSCO Panel nod to study Budesonide, Glycopyrronium and Formoterol Fumarate Dr. Divya Colin20 Oct 2024 5:45 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal for Tozorakimab Study Dr. Divya Colin13 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved AstraZeneca's...
CDSCO Panel Approves AstraZeneca's Protocol Amendment proposal for COPD drug Tozorakimab Dr. Divya Colin5 Sept 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the clinical trial...
CDSCO Panel Approves AstraZeneca's protocol amendment proposal for COPD drug Tozorakimab Dr. Divya Colin19 Aug 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Conduct BE study: CDSCO Panel Tells Sun Pharma Labs on COPD drug Umeclidinium powder for inhalation Dr. Divya Colin31 May 2024 6:00 PM ISTNew Delhi: In line with the proposal to manufacture and market Umeclidinium powder for inhalation 62.5mcg, the Subject Expert Committee (SEC)...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal For COPD Drug Study Dr. Divya Colin5 April 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Sanofi Gets CDSCO Panel Nod to Study COPD drug Itepekimab Dr. Divya Colin26 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sanofi has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves Sanofi's Protocol Amendment proposal for COPD drug Itepekimab Dr. Divya Colin21 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Panel (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Sanofi's...
Conduct bioequivalence study: CDSCO Panel tells Zydus Healthcare on Glycopyrrolate, Indacaterol Metered dose inhalation Dr. Divya Colin22 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the clinical trial waiver proposal, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
